- Phase 2 trial of imatinib mesylate in myelofibrosis with myeloid metaplasia. Tefferi, A., Mesa, R.A., Gray, L.A., Steensma, D.P., Camoriano, J.K., Elliott, M.A., Pardanani, A., Ansell, S.M., Call, T.G., Colon-Otero, G., Schroeder, G., Hanson, C.A., Dewald, G.W., Kaufmann, S.H. Blood (2002)